Dr. Roberts has been continuously funded by the NIH for 40 years, has served on >50 NIH and DOD grant review panels, has co-founded four biotechnology companies in the diagnostic and device space, and holds six issued patents in the clinical therapeutics and diagnostics area. Dr. Roberts’ current research is focused on metabolic comorbidities associated with polycystic ovary syndrome, antiretroviral therapy for HIV, and long COVID using nonhuman primate models.